e&m normal distribution - np.pa alliance 02.26.14
TRANSCRIPT
![Page 1: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/1.jpg)
Evaluation & Management (E/M)
Normal Distribution
Presented by: Katie Roemer, HSA, CPC
![Page 2: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/2.jpg)
Objectives
• CMS bell curves for multiple Evaluation & Management (E&M) codes.
• Case study of distributions under the bell curve for established patient office visit codes (99211 – 99215).
• Overview of documentation requirements for established patient office visit codes (99211 – 99215).
![Page 3: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/3.jpg)
What is Normal Distribution?
Webster’s Dictionary says: “A theoretical frequency distribution represented by a normal curve.” (2010)
CMS says it’s a peer comparison. Where, under the bell curve, do you fall in comparison to your peers?
![Page 4: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/4.jpg)
CMS E/M Normal Distribution
![Page 5: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/5.jpg)
CMS E/M Normal Distribution
![Page 6: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/6.jpg)
CMS E/M Normal Distribution
![Page 7: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/7.jpg)
CMS E/M Normal Distribution
![Page 8: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/8.jpg)
CMS E/M Normal Distribution
![Page 9: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/9.jpg)
CMS E/M Normal Distribution
![Page 10: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/10.jpg)
Case Study
• Per routine audit, CMS identifies 60 midlevel providers who have continually submitted, for payment, a year’s worth of established patient office visits.
• The audit consists of an even amount of Nurse Practitioner and Physician Assistant charges.
• The auditor identifies 14 providers whose records will be requested to verify support of the codes billed.
• Pass rate for this audit: 77%
![Page 11: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/11.jpg)
CMS Specialty Bell Curve: Established Patient Visits
Specialty 99211 99212 99213 99214 99215
NP 3.37% 10.02% 49.84% 33.47% 3.30%
PA 1.84% 12.83% 54.80% 28.25% 2.28%
![Page 12: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/12.jpg)
Audit Results
![Page 13: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/13.jpg)
Outliers
![Page 14: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/14.jpg)
Don’t forget medical necessity!
99211 99212 99213 99214 99215
History N/A Problem Focused
Expanded Problem Focused
Detailed Comprehensive
Exam N/A Problem Focused
Expanded Problem Focused
Detailed Comprehensive
MDM N/A Straight-forward Low Moderate High
Time (minutes) 5 10 15 25 40
![Page 15: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/15.jpg)
99212 Components
3/3 ∙ HPI: 1-3 Elements ∙ ROS: 0 Systems ∙ PFSH: 0 Histories
∙ 1995 DG: 1 organ system/body area
or ∙ 1997 DG: 1-5 bullets
2/3 ≤ ∙ 1 Diagnosis ∙ Minimal Risk ≤ ∙ 1 Data Element
![Page 16: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/16.jpg)
MDM: 99212
Presenting Problem(s)
Diagnostic Procedure(s) Ordered
Management Option(s) Selected
Minimal
One self-limiting or minor :• Problem • Illness• Injury• Condition• Diagnosis
• Lab tests requiring venipuncture• Urinalysis• Ultrasound• X-rays• EKG/EEG• KOH prep
• Rest• Gargles• Elastic bandages• Superficial dressings
![Page 17: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/17.jpg)
99213 Components
3/3 ∙ HPI: 1-3 Elements ∙ ROS: 1 System ∙ PFSH: 0 Histories
∙ 1995 DG: 2-7 organ system/body area
(limited)or
∙ 1997 DG: 6-11 bullets
2/3 ∙ 2 Diagnoses ∙ Low Risk ∙ 2 Data Elements
![Page 18: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/18.jpg)
MDM: 99213
Presenting Problem(s)
Diagnostic Procedure(s) Ordered
Management Option(s) Selected
Low
• 2+ self limiting or minor problems.• 1 stable, chronic illness, diagnosis, condition.• Acute uncomplicated illness or injury.
• Physiologic tests not under stress. • Non-cardiovascular imaging studies with contrast.• Superficial needle biopsies. • Clinical lab tests requiring arterial puncture.•Skin biopsies.
• OTC drugs.•Minor surgery (10-day) with no patient-specific risk factors identified.• PT/OT• IV fluids without additives.
![Page 19: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/19.jpg)
99214 Components
3/3 ∙ HPI: ≥ 4 Elements ∙ ROS: 2-9 Systems ∙ PFSH: 1 History
∙ 1995 DG: 2-7 organ system/body area
(extended)or
∙ 1997 DG: 12+ bullets
2/3 ∙ 3+ Diagnosis ∙ Moderate Risk ∙ 3 Data Elements
![Page 20: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/20.jpg)
MDM: 99214
Presenting Problem(s) Diagnostic Procedure(s) Ordered
Management Option(s) Selected
Moderate
• 1+ chronic condition with mild exacerbation, progression or side effect of treatment.• 2+ stable, chronic conditions. • Undiagnosed new problem with uncertain prognosis.• Acute illness with systemic symptoms.• Acute complicated injury.
• Physiologic tests under stress.• Diagnostic endoscopies with no patient-specific identified risk factors.• Deep needle or incisional biopsy.• Cardiovascular imaging studies with contrast and no patient-specific identified risk factors.• Obtain fluid from body cavity.
• Minor surgery (10-day) with patient-specific identified risk factors.• Elective major surgery (90-day) with no patient-specific identified risk factors. • Rx drug management. •Therapeutic nuclear medicine. • IV fluids with additives.•Closed treatment of fracture or dislocation without manipulation.
![Page 21: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/21.jpg)
99215 Components
3/3 ∙ HPI: ≥ 4 Elements ∙ ROS: 10+ Systems ∙ PFSH: 2-3 Histories
∙ 1995 DG: 8+ organ systems
or ∙ 1997 DG: 18+ bullets
2/3 ≥ ∙ 4 Diagnosis ∙ High Risk ≥ ∙ 4 Data Elements
![Page 22: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/22.jpg)
MDM: 99215Presenting Problem(s)
Diagnostic Procedure(s) Ordered
Management Option(s) Selected
High
• 1+ chronic illness with severe exacerbation, progression, or side effect of treatment. • Acute or chronic illness/injury that poses a threat to life or bodily function. • An abrupt change in neurologic status.
• Cardiovascular imaging studies with contrast with patient-specific identified risk factors. • Cardiac electrophysiological tests.• Diagnostic endoscopies with patient-specific identified risk factors. • Discography
• Elective major surgery (90-day) with patient-specific identified risk factors. • Emergency major surgery (90-day). • Parenteral controlled substances. • Drug therapy requiring intensive monitoring for toxicity. •Decision not to resuscitate, or to de-escalate care because of poor prognosis.
![Page 23: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/23.jpg)
Specialty Distributions
![Page 24: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/24.jpg)
• Report Data: – Provider(s)– Date Range– Procedure Codes– Units
![Page 25: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/25.jpg)
Change numbers to percents
Verify the sum = 100%
![Page 26: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/26.jpg)
![Page 27: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/27.jpg)
Specialty Distributions
![Page 28: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/28.jpg)
![Page 29: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/29.jpg)
![Page 30: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/30.jpg)
Normal Distribution
![Page 31: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/31.jpg)
• http://www.aapcps.com/resources/em_utilization.aspx
![Page 32: E&M Normal Distribution - NP.PA Alliance 02.26.14](https://reader030.vdocuments.net/reader030/viewer/2022032506/55cdd24cbb61ebf7038b47b2/html5/thumbnails/32.jpg)
Thank you!
Any questions?